文献速递瓣膜外科

经验丰富的外科医生实施的机器人二尖瓣手术在1年时成本中性且持久

Robotic mitral valve operations by experienced surgeons are cost-neutral and durable at 1 year.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-04-12

本研究比较了经验丰富的外科医生实施的机器人二尖瓣手术与胸骨正中切开术在30天和1年时的结局与成本。倾向匹配后每组91例,两组总成本相似(机器人组27,662美元 vs 胸骨切开组28,241美元;P=0.273),机器人组早期直接成本较高,胸骨切开组晚期间接成本因住院时间、输血需求和再入院率增加而明显升高。机器人修复技术在1年时无 echocardiographic 复发超过微量至轻度返流。

要点

  • 倾向匹配后机器人组与胸骨切开组总成本相似(27,662美元 vs 28,241美元;P=0.273)。
  • 机器人组早期直接成本较高,胸骨切开组晚期间接成本因住院时间、输血和再入院增加而升高。
  • 机器人修复技术在1年时无 echocardiographic 复发超过微量至轻度返流。

核心结论

  • 经验丰富的二尖瓣外科医生可以以成本中性的方式启动机器人项目,同时维持临床结局的完整性和修复的持久性。

研究设计与样本

  • 2013年4月至2015年10月,连续328例由经验丰富的外科医生实施机器人或胸骨正中切开二尖瓣修复或置换的患者,检查30天和1年结局。
  • 采用多变量逻辑回归指导倾向匹配,得出182例患者的队列。
  • 所有机器人患者完成1年超声心动图随访。
  • 应用详细的作业成本法核算,包括直接、半直接和间接成本,特别关注机器人折旧、维护和耗材。
  • 对所有医院成本进行定量分析,直接应用于每位患者就诊以进行比较性财务分析。

主要发现

  • 机器人组(n=91)和胸骨切开组(n=91)的平均预测死亡风险相似(0.9% vs 0.8%;P>0.431)。
  • 机器人二尖瓣手术的总成本与胸骨切开术相似(27,662美元 vs 28,241美元;P=0.273)。
  • 机器人组早期直接成本较高。
  • 胸骨切开组晚期间接成本明显增加,与住院时间、输血需求和再入院率增加相关。
  • 机器人修复技术在1年时无 echocardiographic 复发超过微量至轻度返流。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic mitral valve surgery has potential advantages in patient satisfaction and 30-day outcome. Cost concerns and repair durability limit wider adoption of robotic technology. This study examined detailed cost differences between robotic and sternotomy techniques in relation to outcomes and durability following robotic mitral program initiation. METHODS: Between April 2013 and October 2015, 30-day and 1-year outcomes of 328 consecutive patients undergoing robotic or sternotomy mitral valve repair or replacement by experienced surgeons were examined. Multivariable logistic regression informed propensity matching to derive a cohort of 182 patients. Echocardiographic follow-up was completed at 1 year in all robotic patients. Detailed activity-based cost accounting was applied to include direct, semidirect, and indirect costs with special respect to robotic depreciation, maintenance, and supplies. A quantitative analysis of all hospital costs was applied directly to each patient encounter for comparative financial analyses. RESULTS: Mean predicted risk of mortality was similar in both the robotic (n = 91) and sternotomy (n = 91) groups (0.9% vs 0.8%; P > .431). The total costs of robotic mitral operations were similar to those of sternotomy ($27,662 vs $28,241; P = .273). Early direct costs were higher in the robotic group. There was a marked increase in late indirect cost with the sternotomy cohort related to increased length of stay, transfusion requirements, and readmission rates. Robotic repair technique was associated with no echocardiographic recurrence greater than trace to only mild regurgitation at 1 year. CONCLUSIONS: Experienced mitral surgeons can initiate a robotic program in a cost-neutral manner that maintains clinical outcome integrity as well as repair durability.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Coyan G, Wei LM, Althouse A, et al. Robotic mitral valve operations by experienced surgeons are cost-neutral and durable at 1 year. J Thorac Cardiovasc Surg. 2018. PMID: 29724597. doi:10.1016/j.jtcvs.2018.03.147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。